Clinical & translational oncology

• 

  Año 2012, Vol. 14, Número 12

  • Depicting the evolving scenario of translational-guided drug development

    Guillem Argilés Martínez, Jordi Rodón, Josep Tabernero Caturla

    págs. 881-882

    

  • Therapeutic nanosystems for oncology nanomedicine

    A. S. Gonçalves, A. S. Macedo, E. B. Souto

    • Resumen

    págs. 883-890

    

  • Role of gamma-delta T-cells in cancer.: Another opening door to immunotherapy

    Diego Márquez Medina, Joel Salla-Fortuny, Antonieta Salud

    • Resumen

    págs. 891-895

    

  • Characteristics and long-term survival of colorectal cancer patients aged 44 years and younger

    Zuli Yang, Liang Kang, Lei Wang, Jun Xiang, Guanfu Cai, Ji Cui, Junsheng Peng, Ping Lan, Jianping Wang

    • Resumen

    págs. 896-904

    

  • Helicobacter pylori infection of the larynx may be an emerging risk factor for laryngeal squamous cell carcinoma

    Hongli Gong, Yi Shi, Liang Zhou, Lei Tao, Yong Shi, Wenjun Cao, Lei Cheng

    • Resumen

    págs. 905-910

    

  • Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer

    Basak Oven Ustaalioglu, Ahmet Bilici, Nagehan Ozdemir Barisik, Mehmet Aliustaoglu, Fugen Aker Vardar, Burcak Erkol Yilmaz, Mesut Seker, Mahmut Gumus

    • Resumen

    págs. 911-922

    

  • Is obesity always a risk factor for all breast cancer patients? c-erbB2 expression is significantly lower in obese patients with early stage breast cancer

    Umut Mousa, Handan Onur, Gungor Utkan

    • Resumen

    págs. 923-930

    

  • Intraperitoneal bevacizumab combined with cytoreductive surgery:: a pre-clinical study of tolerance and pharmacokinetics in an animal model

    Guillaume Passot, Aurélien Dupré, Michel Rivoire, Faheez Mohamed, Naoual Bakrin, Olivier Glehen

    • Resumen

    págs. 931-936

    

  • Study of KRAS new predictive marker in a clinical laboratory

    Inmaculada Bando, Lourdes Cillero, Patricia Llovet, Paula Pescador, Miguel de la Hoya, Trinidad Caldés Llopis, Julián Sanz Ortega, Milagros Ferrer, Javier Sastre Valera, Eduardo Díaz-Rubio García

    • Resumen

    págs. 937-942

    

  • Functional and biologic metrics for predicting radiation pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy

    Dongqing Wang, Jingyu Zhu, J. Sun, Baosheng Li, Zhongtang Wang, Lei Wei, Yong Yin, Hongfu Sun, Zheng Fu, Xingguo Zhang, Zongwei Huo

    • Resumen

    págs. 943-952

    

  • Conservative surgery, external radiotherapy, and HDR brachytherapy in a single fraction of 7 Gy in early breast cancer: long-term toxicity and esthetic assessment

    Aurora Rodríguez Pérez, Concepción López Carrizosa, Pilar Samper Ots, José Fermín Pérez-Regadera Gómez, José Zapatero Ortuño, Juan de Dios Sáez Garrido, Manuel Joaquín Martín de Miguel

    • Resumen

    págs. 953-960

    

  • Comments on �SEOM guidelines for endometrial cancer�

    R. Vergés

    págs. 961-962